iBio Inc (IBIO)
2.45
+0.26
(+11.87%)
USD |
NYAM |
Nov 21, 16:00
2.45
0.00 (0.00%)
After-Hours: 20:00
iBio Max Drawdown (5Y): 99.97% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.97% |
| September 30, 2024 | 99.97% |
| August 31, 2024 | 99.97% |
| July 31, 2024 | 99.97% |
| June 30, 2024 | 99.97% |
| May 31, 2024 | 99.97% |
| April 30, 2024 | 99.97% |
| March 31, 2024 | 99.97% |
| February 29, 2024 | 99.97% |
| January 31, 2024 | 99.97% |
| December 31, 2023 | 99.96% |
| November 30, 2023 | 99.90% |
| October 31, 2023 | 99.84% |
| September 30, 2023 | 99.83% |
| August 31, 2023 | 99.81% |
| July 31, 2023 | 99.76% |
| June 30, 2023 | 99.76% |
| May 31, 2023 | 99.76% |
| April 30, 2023 | 99.76% |
| March 31, 2023 | 99.76% |
| February 28, 2023 | 99.76% |
| January 31, 2023 | 99.76% |
| December 31, 2022 | 99.76% |
| November 30, 2022 | 99.08% |
| October 31, 2022 | 99.04% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.04% |
| August 31, 2022 | 99.04% |
| July 31, 2022 | 99.04% |
| June 30, 2022 | 99.04% |
| May 31, 2022 | 99.04% |
| April 30, 2022 | 99.04% |
| March 31, 2022 | 99.04% |
| February 28, 2022 | 99.04% |
| January 31, 2022 | 99.04% |
| December 31, 2021 | 99.04% |
| November 30, 2021 | 99.04% |
| October 31, 2021 | 99.04% |
| September 30, 2021 | 99.04% |
| August 31, 2021 | 99.04% |
| July 31, 2021 | 99.04% |
| June 30, 2021 | 99.04% |
| May 31, 2021 | 99.04% |
| April 30, 2021 | 99.04% |
| March 31, 2021 | 99.04% |
| February 28, 2021 | 99.04% |
| January 31, 2021 | 99.04% |
| December 31, 2020 | 99.04% |
| November 30, 2020 | 99.04% |
| October 31, 2020 | 99.04% |
| September 30, 2020 | 99.04% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.04%
Minimum
Nov 2019
99.97%
Maximum
Mar 2024
99.36%
Average
99.04%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
| Nanoviricides Inc | 97.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -9.127 |
| Beta (5Y) | -3.332 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 238.0% |
| Historical Sharpe Ratio (5Y) | -0.2191 |
| Historical Sortino (5Y) | -0.7961 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 58.85% |